1. Sweden Stocks

  2. •

    Retail trade

  3. •

    Drugstore chains
Meds Apotek AB

Meds Apotek AB

SSTO:MEDS
22.00
SEK
-1.10
(-4.76%)
0.80EPS
26.63P/E
404.87MMarket Cap
Nov 06Next Earn
Meds Apotek AB
STO:MEDS
(Nasdaq Stockholm)

Recent

price

22.00

P/E

ratio

26.63

div

yld

- -

ROIC.AI

2021
2023
2024
2025
TTM
SEK
- -
39.11
48.07
58.34
59.09
Revenue per Share
- -
-3.05
-0.6
0.45
0.82
Basic EPS, GAAP
- -
-3.48
0.7
-1.67
0.04
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
5.77
3.96
3.4
6.91
7.5
Book Value per Share
5.07
2.92
2.56
6.25
6.86
Tangible Book Value per Share
1
17
17
17
18
Basic Weighted Avg Shares
- -
655
829
1,006
1,080
Sales/Revenue/Turnover
- -
-7.52
-1.01
-0.25
0.43
Operating Margin (%)
- -
21
21
20
19
Depreciation Expense
- -
-51
-10
8
15
Net Income, GAAP
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
-7.79
-1.25
0.77
1.39
Profit Margin (%)
65
54
25
89
100
Working Capital
34
49
16
- -
- -
LT Debt
91
68
59
128
139
Total Equity
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-63.9
-16.37
8.26
- -
Return on Common Equity (%)

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
7
5
2
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
19
19
Market Capitalization
925
550
405

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
230
244
234
Cash, Cash Equivalents & STI
45
72
67
Accounts Receivable, Net
26
29
24
Inventories
144
136
129
Total Current Liabilities
141
152
133
Payables & Accruals
- -
- -
- -
ST Debt
7
5
2
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
118.8%
Free Cash Flow
- -
- -
-339.11%
Net Income, GAAP
- -
- -
-174.28%
Sales/Revenue/Turnover
- -
- -
21.37%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
205
223
829
2025
242
258
249
258
1,006
2026
270
304
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
-0.05
-0.01
-0.6
2025
0.31
-0.1
-0.33
0.53
0.45
2026
0.28
0.31
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
CVS Health Corporation (NYSE:CVS)
MatsukiyoCocokara & Co. (TSE:3088)
Guardian Pharmacy Services, Inc. (NYSE:GRDN)
TSURUHA Holdings, Inc. (TSE:3391)
MedPlus Health Services Ltd. (NSE:MEDPLUS)
Raia Drogasil S.A. (B3:RADL3)
Business
Meds Apotek AB operates as a full-service online pharmacy and e-commerce healthcare retailer in Sweden. The company distributes and retails prescription pharmaceuticals; over-the-counter (OTC) medications; vitamins, minerals, and dietary supplements; dermatological skincare, beauty, and cosmetic products; personal hygiene and oral care goods; maternal and baby healthcare items; intimate wellness products; and veterinary pharmaceuticals and pet health supplies. In addition, the company provides automated electronic prescription management, remote pharmacist advisory consultations, and rapid doorstep delivery logistics across Swedish urban markets. In recent developments, Meds Apotek AB expanded its logistics operations through high-efficiency automated fulfillment systems at its central distribution facility to accelerate order processing times and increase volume capacity. The company has also strengthened strategic partnerships with Nordic telehealth platforms to streamline digital prescription transfers, expanded its portfolio of specialized dermo-cosmetics and veterinary products, and optimized its capital structure through institutional financing rounds to support market expansion and profitability across the Nordic e-pharmacy market. Meds Apotek AB was founded in 2017 and is headquartered in Stockholm, Sweden.